Can Drinking Coffee Affect Colon Cancer Progression or Survival?

Drinking coffee continues to be associated with improved outcomes in patients with colorectal cancer, although a cause-and-effect relationship remains unproven. Previously, coffee-drinking patients with colorectal cancer classified as stage 3 — affecting lymph nodes but not spread to other organs — had been shown to have a lower risk of cancer recurrence and death than … Read more

Five Things You Need to Know About Colorectal Cancer Prevention [Infographic]

Updated April 13, 2015 While one of the most common cancers in both men and women, colorectal cancer remains a very preventable disease, says Jeffrey Meyerhardt, MD, MPH, clinical director of Dana-Farber’s Center for Gastrointestinal Oncology. “Most of these cancers develop over a period of years,” he says. “While not preventable in everyone, the earlier … Read more

Survivor Uses Reiki and ‘Button Therapy’ to Help Others Facing Cancer

As a girl, Paula Kaufman loved playing with the buttons that her grandmother, a seamstress, had in abundance. Later, while in treatment for stage III colorectal cancer at Dana-Farber Cancer Institute, Kaufman – then a mother of three in her late 30s – gained strength from a jar of buttons her grandmother bequeathed to her. … Read more

50 Years of Discovery: Advances in Colorectal Cancer Treatment

The fight against cancers of the digestive system – including colorectal, stomach, esophageal, hepatic, and pancreatic cancers – has made significant progress in the past 50 years, especially in prevention and early diagnosis of colorectal cancer, where screening with tests such as colonoscopies is continuing to make a major impact. “In some areas we have done … Read more

Colorectal Cancer: Five Things You Need to Know

Colorectal cancer is the fourth most common cancer in the U.S., with about 143,000 new patients diagnosed last year. But thanks to increased awareness about screenings, the death rate from colorectal cancer has been dropping for more than 20 years.

Jeffrey Meyerhardt, MD, MPH
Jeffrey Meyerhardt, MD, MPH

“For the most part, colorectal cancer is a curable and preventable disease,” says Jeffrey Meyerhardt, MD, MPH, clinical director of the Dana-Farber Gastrointestinal Cancer Treatment Center. “We have very good data that shows screening prevents disease and saves lives.”

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about the disease:

Read more

Why Should I Get a Colonoscopy? (Colorectal Cancer)

Colonoscopy exams get a bad rap. Even though such exams are brief and painless, many people fear and avoid them. Roughly one third of Americans for whom the exams are recommended are not getting them. Yet colonoscopy is one of the most effective of all cancer prevention methods. As many as 60% of colon cancer deaths could be … Read more

Cancer Researcher Values Teaching and Learning

By William Hahn, MD, PhD

Every year, hundreds of postdoctoral fellows and graduate students study cancer research at Dana-Farber under some of the world’s leading scientists. The Dana-Farber Postdoc and Graduate Student Affairs Office recently named the first recipient of its Mentor-of-the-Year Award: William Hahn, MD, PhD, the Institute’s deputy scientific officer and director of its Center for Cancer Genome Discovery. Here, Hahn discusses the lessons he learned from his own mentors and his efforts to instill the same principles in his own trainees.

Read more